SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001214659-23-006561
Filing Date
2023-05-05
Accepted
2023-05-05 16:24:36
Documents
16
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 bp5523020fa1.htm   iXBRL 20-F/A 58075
2 EXHIBIT 12.1 ex12_1.htm EX-12.1 3771
3 EXHIBIT 15.1 ex15_1.htm EX-15.1 6433
8 GRAPHIC mazars_logo.jpg GRAPHIC 11587
  Complete submission text file 0001214659-23-006561.txt   350435

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE mtp-20221231.xsd EX-101.SCH 2860
5 XBRL DEFINITION FILE mtp-20221231_def.xml EX-101.DEF 27632
6 XBRL LABEL FILE mtp-20221231_lab.xml EX-101.LAB 37944
7 XBRL PRESENTATION FILE mtp-20221231_pre.xml EX-101.PRE 26278
10 EXTRACTED XBRL INSTANCE DOCUMENT bp5523020fa1_htm.xml XML 9053
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Filer) CIK: 0001643918 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 001-37652 | Film No.: 23894234
SIC: 2834 Pharmaceutical Preparations